158
Views
6
CrossRef citations to date
0
Altmetric
CAUSATION AND PREVENTION

Polymorphisms in Interleukin-6-6331 Influences the Susceptibility of a Chinese Population to Gastric Cancer

, , , , , , & show all
Pages 564-572 | Published online: 15 Aug 2011

REFERENCES

  • Ponder BA. Cancer genetics. Nature 2001; 411:336–341.
  • Bodger K, Crabtree JE. Helicobacter pylori and gastric inflammation. Med Bull 1998;54:139–150.
  • Hirano T. Interleukin-6 and its relation to inflammation and disease. Clin Immunol Immunopathol 1992;62:S60–S65.
  • Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860–867.
  • Ardies CM. Inflammation as a cause for scar cancers of the lung. Integr Cancer Ther 2003;2:238–246.
  • Wiseman H, Halliwell B. Damage to DNA by reactive oxygen and nitrogen species: Role in inflammatory disease and progression to cancer. Biochem J 1996;313:17–29.
  • Hefler LA, Grimm C, Ackermann S, Malur S, Radjabi-Rahat AR, Leodolter S, Beckmann MW, Zeillinger R, Koelbl, H, Tempfer CB. An interleukin-6 gene promoter polymorphism influences the biological phenotype of ovarian cancer. Cancer Res 2003;63:3066–3068.
  • Iacopetta B, Grieu F, Joseph D. The 174 G/C gene polymorphism in interleukin-6 is associated with an aggressive breast cancer phenotype. Br J Cancer 2004;90:419–422.
  • DeMichele A, Martin AM, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B. Interleukin-6 174G–>C polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res. 2003;63:8051–8056.
  • Yamamoto T, Matsuda T, Junicho A, Kishi H, Saatcioglu F, Muraguchi A. Cross-talk between signal transducer and activator of transcription 3 and estrogen receptor signaling. FEBS Lett 2000;486:143–148.
  • Matsuo K, Oka M, Murase K, Soda H, Isomoto H, Takeshima F, Mizuta Y, Murata I, Kohno S. Expression of interleukin 6 and its receptor in human gastric and colorectal cancers. J Int Med Res 2003;31:69–75.
  • Wu CW, Wang SR, Chao MF, Wu TC, Lui WY, P'eng FK, Chi CW. Seruminterleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol 1996;91:1417–1422.
  • Tang LP, Cho CH, Hui WM, Huang C, Chu KM, Xia HH, Lam SK, Rashid A, Wong BC, Chan AO. An inverse correlation between interleukin-6 and select gene promoter methylation in patients with gastric cancer. Digestion 2006;74:85–90.
  • Thong-Ngam D, Tangkijvanich P, Lerknimitr R, Mahachai V, Theamboonlers A, Poovorawan Y. Diagnostic role of serum interleukin-18 in gastric cancer patients. World J Gastroenterol 2006;12:4473–4477.
  • Liao WC, Lin JT, Wu CY, Huang SP, Lin MT, Wu AS, Huang YJ, Wu MS. Serum interleukin-6 level but not genotype predicts survival after resection in stages II and III gastric carcinoma. Clin Cancer Res 2008;14:428–434.
  • Bennermo M, Held C, Stemme S, Ericsson CG, Silveira A, Green F, Tornvall P. Genetic predisposition of the interleukin-6 response to inflammation: implications for a variety of major diseases? Clin Chem 2004;50:2136–2140.
  • Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138–18144.
  • Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369–1376.
  • DeVita F, Romano C, Orditura M, Galizia G, Martinelli E, Lieto E, Catalano G. Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res 2001;21: 45–52.
  • Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC. The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 2001;11:699–701.
  • Lim CS, Zheng S, Kim YS, Ahn C, Han JS, Kim S, Lee JS, Chae DW. The -174 G to C polymorphism of interleukin-6 gene is very rare in Koreans. Cytokine 2002;19:52–54.
  • Nakajima T, Ota N, Yoshida H, Watanabe S, Suzuki T, Emi M. Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1999;1:115–119.
  • Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T. Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 2002;19:1000–1005.
  • Smith AJ, D'Aiuto F, Palmen J, Cooper JA, Samuel J, Thompson S, Sanders J, Donos N, Nibali L, Brull D, Woo P, Humphries SE. Association of serum interleukin-6 concentration with a functional IL6-6331T>C polymorphism. Clin Chem 2008;54:841– 850.
  • Parsonnet J, Friedman GD, Vandersteen DP, Chang Y, Vogelman JH, Orentreich N, Sibley RK. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127–1231.
  • Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001;49:347–353.
  • Driessen A, Van Raemdonck D, De Leyn P, Filez L, Peeters M, Winnepenninckx V, Penninckx F, Lerut T, Ectors N. HP Belgian Contact Group. Are carcinomas of the cardia oesophageal or gastric adenocarcinomas? Eur J Cancer 2003;39:2487–2494.
  • Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1–9.
  • Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784–789.
  • Hansen S, Vollset SE, Melby K, Aase S, Jellun E, Fyfe V, Ferguson J, Mccoll KEL. Gastric mucosal atrophy is a strong predictor of non-cardia gastric cancer but not of cardia cancer. Gastroenterology 1998;114:G2491.
  • Lagergren J, Ye W, Lindgren A, Nyrén O, Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev 2000;9:757–760.
  • Marrelli D, Pedrazzani C, Berardi A, Corso G, Neri A, Garosi L, Vindigni C, Santucci A, Figura N, Roviello F. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer 2009;115:2071–2080.
  • Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol 1995;19:S37–S43.
  • Solcia E, Fiocca R, Luinetti O, Villani, L, Padovan L, Calistri D, Ranzani GN, Chiaravalli A, Capella C. Intestinal and diffuse gastric cancers arise in a different background of Helicobacter pylori gastritis through different gene involvement. Am J Surg Pathol 1996;20:S8–S22.
  • Carneiro F, Seixas M, Sobrinho-Simo∼es M. New elements for an updated classification of the carcinomas of the stomach. Pathol Res Pract 1995;191:571–584.
  • Tanahashi T, Kita M, Kodama T, Yamaoka Y, Sawai N, Ohno T, Mitsufuji S, Wei YP, Kashima K, Imanishi J. Cytokine expression and production by purified Helicobacter pylori urease in human gastric epithelial cells. Infect Immun 2000;68:664– 671.
  • Bronte-Tinkew DM, Terebiznik M, Franco A, Ang M, Ahn D, Mimuro H, Sasakawa C, Ropeleski MJ, Peek RM, Jones NL. Helicobacter pylori cytotoxin-associated gene A activates the signal transducer and activator of transcription 3 pathway in vitro and in vivo. Cancer Res 2009;69:632–639.
  • Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, Yamaoka Y. Interleukin-6 genetic polymorphisms are not related to Helicobacter pylori-associated gastroduodenal diseases. Helicobacter 2003;8:142–148.
  • Brull DJ, Montgomery HE, Sanders J, Dhamrait S, Luong L, Rumley A, Lowe GD, Humphries, S.E. Interleukin-6 gene -174g>c and -572g>c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458–1463.
  • Boiardi L, Casali B, Farnetti E, Pipitone N, Nicoli D, Cantini F, Macchioni P, Bajocchi G, Catanoso MG, Pulsatelli L, Consonni D, Salvarani C. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica. J Rheumatol 2006;33:703–708.
  • Ravaglia G, Forti P, Maioli F, Chiappelli M, Dolzani P, Martelli M, Bianchin M, Mariani E, Bolondi L, Licastro F. Associations of the -174 G/C interleukin-6 gene promoter polymorphism with serum interleukin 6 and mortality in the elderly. Biogerontology 2005;6:415–423.
  • Walston J, Arking DE, Fallin D, Li T, Beamer B, Xue Q, Ferrucci L, Fried LP, Chakravarti A. IL-6 gene variation is not associated with increased serum levels of IL-6, muscle, weakness, or frailty in older women. Exp Gerontol 2005;40:344–352.
  • Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369–1376.
  • Gatti LL, Burbano RR, Zambaldi-Tunes M, de-Lábio RW, de Assumpção PP, de Arruda Cardoso-Smith M, Marques-Payão SL. Interleukin-6 polymorphisms, Helicobacter pylori infection in adult Brazilian patients with chronic gastritis and gastric adenocarcinoma. Arch Med Res 2007;38:551–555.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.